Ajay Major shared a post on X:

“VIPOR R/R Primary central nervous system lymphoma /non-GC Secondary central nervous system lymphoma

Mark Roschewski, ASH24:

14 patients, most PCNSL
Objective response rate 62 percent / Complete remission 31 percent (ORR 67 percent / CR 22 percent if prior BTKi)
8 donation after circulatory death early, half d/t progression
71 percent diarrhea, 50 percent hypoK Multiple CNS-penetrating agents in VIPOR; should this be followed with consolidation? “

VIPOR for Diffuse Large B-Cell Lymphoma involving the Central Nervous System

Ajay Major is an Assistant Professor of Medicine at the University of Colorado School of Medicine, specializing in lymphoma and CLL/SLL. He is the Founder and President of Pager Publications, as well as the Founder and Editor-in-Chief of in-House. Additionally, he serves as a Reviewer for the Bellevue Literary Review.